Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Twist Bioscience Corp (TWST) Price & Performance

Elanco Animal Health Incorporated Common StockTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Elanco Animal Health Incorporated Common Stock vs Twist Bioscience Corp — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.62 (market cap $11.17B), while Twist Bioscience Corp trades at $157.03 (market cap $10.32B). The key difference: Elanco Animal Health Incorporated Common Stock and Twist Bioscience Corp are close in size by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Elanco Animal Health Incorporated Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Twist Bioscience Corp for 27 Days on average.

ELANTWST
Market Cap
$11.17B$10.32B
Volume
4,196,2425,894,998
Sector
HealthHealth
52-Week High
$26.84$205.00
52-Week Low
$19.76$25.45
Typical Hold Time
0 Days27 Days
Enterprise Value
$14.56B$10.24B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Elanco Animal Health Incorporated Common Stock

No Aura AI signal available yet.

Twist Bioscience Corp

TWST trades at $152.05, down 8.94% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $376.57 million in 2025, but profitability remains elusive with a net income margin of -31.66%. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, providing a potential growth catalyst amid ongoing losses.

The outlook is mixed; analyst consensus is bullish with a $145.20 price target, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on the company's ability to monetize its AI collaborations and achieve profitability, while downside risks include cash burn and competitive pressures in the biotech sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ELAN
100% Buy0% Sell
Avg holding period · 0 Days
TWST
37% Buy63% Sell
Avg holding period · 27 Days

Top news

Latest headlines on both assets

About Elanco Animal Health Incorporated Common Stock

Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.

Read more on ELAN →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST →